EN
HI

Bafna Pharmaceuticals Share price

BAFNAPH

89.01

0.01 (0.01%)
NSE
BSE
Last updated on 23 Jul, 2025 | 13:33 IST
BUYSELL
Today's High

90.50

Today's Low

88.01

52 Week Low

69.00

52 Week High

94.99

The current prices are delayed, login to your account for live prices

Bafna Pharmaceuticals Chart

Bafna Pharmaceuticals Share Key Metrics

Volume
1579.00
Market Cap
210.54 CR
LTQ@LTP
1@89.01
ATP
89.05
Var Margin
25 %
Circuit Range
84.55-93.45
Delivery %
81.7 %
Value
1.41 L
ASM/GSM
No
Market Lot
1

Bafna Pharmaceuticals Futures & Options

Data Not Found

Bafna Pharmaceuticals Corporate Actions

DateAgenda
No Data Found
DateEvent TypeAgenda
No Data Found

Bafna Pharmaceuticals News

In talks with multinational pharma cos for acquisition of brands: Bafna pharmaceuticals

Nov 14 2021 17:15:23

In talks with multinational pharma cos for acquisition of brands: Bafna pharmaceuticals

Nov 14 2021 16:45:37

Bafna Pharmaceuticals Ltd Q2 net profits grow 89%

Nov 14 2021 14:15:35
Read More

About Bafna Pharmaceuticals

NSE : 17742  
BSE : 532989  
ISIN : INE878I01022  

Bafna was incorporated on March 28 1995 with the Registrar of Companies Tamilnadu and acquired the entire business of Bafna Pharmaceutical a proprietary concern of Mr. Bafna Mahaveer Chand.Bafna Pharmaceutical has been engaged in the business of manufacturing pharmaceutical formulations of Betalactam and Non Betalactam products. The first manufacturing unit was set up at Madhavaram during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a. Subsequently the capusule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990.Major events in the History of the Company:Year Event1981 Started as a Proprietorship concern1984 Set up its first manufacturing unit on 04.10.1984 at Madhavaram with tablet line of installed capacity of 420 Lacs p.a.1987 Added Capsules Line with installed capacity of 300 lacs p.a.1990 Added Liquid Line with installed capacity of 45000 ltr. p.a. Made its first supplies to Government of Tamilnadu1994 Started Contract Manufacturing activity for Crossland Laboratories WHO GMP Certification for Madhavarm Unit received Submitted Dossier for registration for 57 products in Srilanka Made its first export to Srilanka1995 Started Supply to ESI corporation.2003 Received Export House" Status by Ministry of Commerce & Industry2005 Best Supplier" Award by State Pharmaceuticals Corporation of Sri Lanka Started Construction of new plant at Grantlyon village Madhavaram Plant approved as per revised Schedule ?M? 2006 Registered 4 products in Ukraine. New plant at Grantlyon Inaugurated by Governor of Tamil Nadu on 02.10.2006. Received ISO 9001: 2000 certificate2007 Inspection by Ghana Inspectors in 2007 got accreditation. Rated as "SE2A" by Dun & Bradstreet Manufacturing Licence Received for Grantlyon Unit WHO GMP Certification for Grantlyon Unit

Bafna Pharmaceuticals Management

NamePosition
Mrs. S Hemalatha Whole Time Director
Mrs. Akila C Raju Non Exe.Non Ind.Director
Ms. R Chitra Ind. Non-Executive Director
Mr. B Kamlesh Kumar Ind. Non-Executive Director
Mr. P K Sundaresan Ind. Non-Executive Director
Read More

Bafna Pharmaceuticals FAQs

The Buying Price of Bafna Pharmaceuticals share is 89.01 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Bafna Pharmaceuticals share log in to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of Bafna Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Bafna Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.

To assess Bafna Pharmaceuticals’s valuation compare Sector P/E, P/B which are 35.97 & 3.94 with sector averages, along with growth rates and financial metrics.

The Market Cap of Bafna Pharmaceuticals is 210.54 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Bafna Pharmaceuticals share price is 94.99 & 69.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.